Newcastle University is part of a new national network which will accelerate innovation across nucleic acids such as DNA and ...

Boehringer Ingelheim has put up 407.5 million euros ($478 million) in biobucks to secure global rights to a first‑in‑class ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...

As Bicara Therapeutics lines up for a potential accelerated cancer drug approval next year, the biotech has appointed Chris Sarchi as its chief commercial officer. | As Bicara Therapeutics lines up ...

A Bristol-based biotech firm has made major advances towards developing a vaccine for hantavirus. EnsiliTech, based at ...

Founder Patrick Soon-Shiong hinted at expansion plans in Turkey, saying on X that “Global expansion” is underway. ・Soon-Shiong also revealed that ImmunityBio’s AI-driven NK-cell manufacturing robot is ...

Breakthroughs in gene editing, AI-driven drug discovery, and in vivo CAR-T therapies are moving from experimental stages to clinical and commercial reality in 2026. Regulatory reforms, market rebounds ...

Significant news coverage and COVID-19 flashbacks have driven investors into biotech stocks over the past week.

But what if one of them encounters significant competition soon? That's what some investors believe might happen, given ...

An expert from Northway Biotech and Lithuania’s Minister of Economy and Innovation talk about how the country is poised to be ...

Dr. Andrew Snyder (Monash University) joins the show to discuss the current biotech landscape: rising M&A and IPO activity, ...

Animal-free dairy is entering a reset phase, with one startup abandoning the “build first, scale later” approach in favor of ...